Concepedia

Author

Debra Armstrong

University of California San Diego

Also Known As

D. A. Armstrong, DEBRA ARMSTRONG, Debra A Armstrong, Debra A. Armstrong, Debra Armstrong

12

Publications

707

Citations

9

H-Index

25

Concepts

All Affiliations

University of California San DiegoVA San Diego Healthcare SystemEli Lilly (United States)Eli Lilly (Singapore)
DA

About

Debra Armstrong is an author at University of California San Diego specializing in body composition, health sciences, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

75

2

Medicine

2

2

75

3

Education

1

1

21

4

Public Health

1

1

21

5

Biochemistry

1

1

46

Debra Armstrong

×

9

Publications

704

Citations

9

H-Index

YearCitations

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong,

The Journal of Clinical Endocrinology & Metabolism

2013

248

Differential Effects of Metformin and Troglitazone on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

Neelima V. Chu, Alice P.S. Kong, Dennis Dong Hwan Kim,

Diabetes Care

2002

195

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

Robert R. Henry, Sunder Mudaliar, Theodore P. Ciaraldi,

Diabetes Care

2014

58

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

Sunder Mudaliar, Debra Armstrong, Annie A. Mavian,

Diabetes Care

2012

52

Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion

Yolanta T. Kruszynska, Mim I. Mulford, Joseph G. Yu,

Diabetes

1997

46

Intravenous Glargine and Regular Insulin Have Similar Effects on Endogenous Glucose Output and Peripheral Activation/Deactivation Kinetic Profiles

Sunder Mudaliar, Pharis Mohideen, Reena Deutsch,

Diabetes Care

2002

36

Young and Elderly Type 2 Diabetic Patients Inhaling Insulin with the AERx® Insulin Diabetes Management System: A Pharmacokinetic and Pharmacodynamic Comparison

Robert R. Henry, Sunder Mudaliar, Neelima V. Chu,

The Journal of Clinical Pharmacology

2003

29

Bovine fascioliasis

J. B. Malone, A. F. Loyacano, Debra Armstrong,

The Bovine Practitioner

1982

21

Reduced peripheral activity leading to hepato‐preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Sunder Mudaliar, Robert R. Henry, Theodore P. Ciaraldi,

Diabetes Obesity and Metabolism

2016

19

Page 1